Tuas, Singapore

API Manufacturing for Oligonucleotides, Peptides & Conjugates

• 20 Emerald Hill Road, Singapore (229302)

Coming soon. Phase I of this new 50-acre site includes 2 API manufacturing plants for small molecule drug, 1 large-scale manufacturing plant for oligonucleotides, peptides, and related synthetic conjugates. The 1 st plant is expected to start operation in 2027.

In the future, the site will add at least 4 more plants, supporting small molecule, oligonucleotide and peptide manufacturing.

Site Virtual Tour

Site Related News

WuXi AppTec Plans to Build a New Site in Singapore, Better Serving Global Partners and Advancing Healthcare Innovation

SINGAPORE, July 19, 2022 – WuXi AppTec, a leading global provider of R&D and manufacturing services that enable the global pharmaceutical and he...

Read More

WuXi AppTec Breaks Ground on New Site in Singapore to Better Support Global Customers

Photo caption (from left to right):

Ms. Cindy Koh, Executive Vice President, Singapore Economic Development Board; Dr. Minzhang Chen, Co-CEO, WuXi Ap...

Read More

WuXi AppTec Plans to Build a New Site in Singapore, Better Serving Global Partners and Advancing Healthcare Innovation

SINGAPORE, July 19, 2022 – WuXi AppTec, a leading global provider of R&D and manufacturing services that enable the global pharmaceutical and he...

Read More

WuXi AppTec Breaks Ground on New Site in Singapore to Better Support Global Customers

Photo caption (from left to right):

Ms. Cindy Koh, Executive Vice President, Singapore Economic Development Board; Dr. Minzhang Chen, Co-CEO, WuXi Ap...

Read More